Board Meetings for NEOGEN
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| NEOGEN | Neogen Chemicals Limited | 13 May 2023 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and dividend | |
| NEOGEN | Neogen Chemicals Limited | 13 May 2023 | NEOGEN CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend. | Board Meeting Intimation | |
| NEOGEN | Neogen Chemicals Limited | 11 Feb 2023 | Financial Results | To consider and approve the financial results for the period ended December 31, 2022 | |
| NEOGEN | Neogen Chemicals Limited | 05 Nov 2022 | Financial results | Neogen Chemicals Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2022 to consider financial statements for the period ended September 2022 | |
| NEOGEN | Neogen Chemicals Limited | 06 Aug 2022 | Financial results | Neogen Chemicals Limited has informed the Exchange about Board Meeting to be held on 06-Aug-2022 to consider financial statements for the period ended June 2022 | |
| NEOGEN | Neogen Chemicals Limited | 14 May 2022 | Dividend/Financial results | Neogen Chemicals Limited has informed the Exchange about Board Meeting to be held on 14-May-2022 to consider financial statements for the period ended March 2022 and Dividend. Pursuant to regulation 29 and 33 of the Listing Regulations, notice is hereby given that a meeting of the Board of Directors of the Company is schedule to be held on Saturday, May 14, 2022, inter-alia, to consider, approve and take on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2022 and to consider recommendation of a final dividend, if any, on the equity shares of the Company, for the financial year ended March 31, 2022 subject to declaration and approval of the same by the shareholders at the ensuing Annual General Meeting. | |
| NEOGEN | Neogen Chemicals Limited | 29 Jan 2022 | Financial Results | To consider and approve the financial results for the period ended December 31, 2021 | |
| NEOGEN | Neogen Chemicals Limited | 08 Dec 2021 | Fund Raising | To consider Fund Raising | |
| NEOGEN | Neogen Chemicals Limited | 30 Oct 2021 | Financial Results | To consider and approve the financial results for the period ended September 30, 2021 | |
| NEOGEN | Neogen Chemicals Limited | 07 Aug 2021 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters | |
| NEOGEN | Neogen Chemicals Limited | 29 May 2021 | Financial Results/Dividend | To consider and approve the Audited financial results for the quarter and financial year ended March 31, 2021 and dividend | |
| NEOGEN | Neogen Chemicals Limited | 13 Feb 2021 | Financial Results | To consider and approve the financial results for the period ended December 31, 2020 | |
| NEOGEN | Neogen Chemicals Limited | 07 Nov 2020 | Financial Results | To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2020 | |
| NEOGEN | Neogen Chemicals Limited | 08 Aug 2020 | Financial Results | Pursuant to regulation 29 and 33 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ), notice is hereby given that a meeting of the Board of Directors of the Company is schedule to be held on Saturday, August 8, 2020 through video conferencing due to COVID- 19 pandemic, inter-alia, to consider, approve and take on record the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30, 2020, along with limited review report of the Statutory Auditors thereon. | |
| NEOGEN | Neogen Chemicals Limited | 23 May 2020 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2020 and to consider recommendation of a final dividend, if any, on the equity shares of the Company, for the financial year ended March 31, 2020 |